TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Viemed Healthcare ( (VMD) ).
Viemed Healthcare reported a strong financial performance for the first quarter of 2025, with a 17% increase in net revenues and a 64% rise in net income compared to the same period in 2024. The company also announced plans to acquire Lehan’s Medical Equipment for $26 million, which is expected to bolster its growth in the respiratory and home medical equipment sectors. Viemed’s strategic investments in sales and technology have contributed to its improved financial outlook, and the acquisition is anticipated to complement its existing operations, further enhancing its market position.
Spark’s Take on VMD Stock
According to Spark, TipRanks’ AI Analyst, VMD is a Outperform.
Viemed Healthcare’s overall score reflects its strong financial health and positive growth outlook, driven by robust revenue trends and strategic acquisitions. However, concerns over high valuation, declining net margins, and free cash flow volatility temper the outlook. The technical indicators suggest mixed short-term momentum, and the positive earnings call guidance and strategic acquisitions provide a supportive backdrop for future growth.
To see Spark’s full report on VMD stock, click here.
More about Viemed Healthcare
Viemed Healthcare, Inc. is a national leader in respiratory care and technology-enabled home medical equipment services. The company focuses on providing respiratory care solutions and home medical equipment, with a market emphasis on enhancing patient care through advanced technology and services.
Average Trading Volume: 120,446
Technical Sentiment Signal: Sell
Current Market Cap: $292.5M
Find detailed analytics on VMD stock on TipRanks’ Stock Analysis page.